Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The oncology devices market is rapidly evolving, driven by advancements in technology and increasing cancer diagnosis rates worldwide. As healthcare providers strive to improve cancer treatments and early detection, the demand for innovative oncology devices continues to soar. Let’s explore the market’s size, growth factors, key players, and emerging trends shaping the future of this critical healthcare segment.

Forecasted Expansion of the Oncology Devices Market in the Coming Years

The oncology devices market has experienced significant growth recently and is anticipated to continue on this trajectory. From $177.72 billion in 2025, it is projected to rise to $210.15 billion in 2026, reflecting a compound annual growth rate (CAGR) of 18.2%. This past growth is largely attributed to the rising global incidence of cancer, the expansion of hospital oncology departments, increasing demand for early diagnostic technologies, availability of advanced imaging devices, and greater awareness around cancer screening initiatives. Looking ahead, the market is expected to reach $397.27 billion by 2030, growing at a CAGR of 17.3%. Factors contributing to this future growth include wider adoption of personalized cancer treatment devices, heightened investments in oncology infrastructure, the growth of outpatient cancer care centers, increased use of AI-powered diagnostic tools, and a stronger focus on precision oncology solutions. Key trends during this period involve the rising uptake of advanced diagnostic devices, image-guided therapies, minimally invasive treatment tools, enhanced radiation therapy technologies, and efforts toward earlier cancer detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp

Factors Fueling the Rise of the Oncology Devices Market – Part One

One of the primary drivers behind the oncology devices market’s expansion is the growing demand for chemotherapy treatments. Chemotherapy, which involves powerful drugs targeting rapidly dividing cells to halt tumor growth, is increasingly sought after due to the rising number of cancer diagnoses worldwide. As more patients are identified, the need for effective and accessible chemotherapy treatments grows accordingly. Oncology devices play a crucial role in supporting chemotherapy by enabling safer and more precise drug delivery and monitoring, which helps improve treatment outcomes and patient safety.

Factors Fueling the Rise of the Oncology Devices Market – Part Two

For instance, the U.S. National Cancer Institute projected in January 2025 that the number of new cancer cases in the United States would reach 2.04 million, up from 1.96 million in 2023. This significant increase underscores the expanding need for chemotherapy administration systems and other oncology devices designed to enhance treatment efficacy. Thus, the rising incidence of cancer and the corresponding increase in chemotherapy demand are key factors propelling market growth.

Access The Complete Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Breaking Down the Oncology Devices Market Segmentation and Revenue Streams

The oncology devices market is categorized according to device type, therapy type, and end user. Device types include brachytherapy devices and endoscopic devices. Therapy classifications cover chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. End users typically consist of hospitals, cancer research institutes, and other healthcare facilities. Within brachytherapy devices, subsegments involve afterloaders (both high-dose rate and low-dose rate), applicators, seeds, and accessories. Endoscopic devices are further segmented into flexible, rigid, and capsule endoscopes, endoscopic ultrasound systems, and related accessories.

Key Technological Advances and Market Trends Shaping the Oncology Devices Future

Leading companies in the oncology devices space are focusing on developing precision-driven and technologically advanced solutions that enhance treatment accuracy, patient safety, and clinical operations. There is a strong emphasis on minimally invasive technologies, improved visualization, and real-time therapy adjustments to support better outcomes across a range of cancers. For example, in April 2025, ZEISS, a medical technology firm based in Germany, obtained FDA 510(k) clearance for its next-generation INTRABEAM 700 system. This robotic-assisted intraoperative radiotherapy platform targets neuro-oncology and breast cancer cases with improved precision, ergonomic design, and seamless integration into surgical workflows. It allows for localized radiation delivery during surgery while minimizing exposure to healthy tissues. By combining advanced imaging, robotics, and treatment planning, the INTRABEAM 700 exemplifies the shift toward sophisticated, patient-focused oncology care.

Prominent Players Competing in the Oncology Devices Market

The oncology devices market features several key organizations driving innovation and competition. These include Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., and Navidea Biopharmaceuticals Inc. These companies continuously invest in research and development to offer cutting-edge oncology devices.

Global Market Distribution and Emerging Regional Opportunities in Oncology Devices

In 2025, North America dominated the oncology devices market as the largest regional segment. Following closely, Asia-Pacific ranked as the second-largest market. The oncology devices market report also covers important regions such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and emerging opportunities across these territories.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model